Tozorakimab (MEDI3506) met its primary and key secondary end points in the Phase 3 OBERON ( NCT05166889) and TITANIA ( ...

Lean-mass changes should be interpreted with performance endpoints, including handgrip strength, rather than isolated ...

Documentation limitations were the most frequently identified theme and included the absence of structured menopause-specific ...

Children and adolescents with type 1 diabetes (T1D) who begin continuous glucose monitoring (CGM) within the first month of ...

Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...

Real-world effectiveness is limited, with 60%–70% not achieving optimal glycemic control after 1 year on GLP-1 therapy, ...

FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...

Menopausal hormone therapy (MHT) initiated during perimenopause or early postmenopause was associated with a 22% reduction in cardiovascular disease (CVD) risk among women with va ...

According to a study in The Lancet Microbe, genomic surveillance and broader vaccine targeting are significant factors in ...

Enrolled participants were predominantly vertically infected, long-term suppressed adolescents; dosing transitioned from initial injections to maintenance every 8 weeks, with median follow-up ...

As The Guardian reports, Goldman is an infectious disease expert with decades of experience in his field, and throughout his entire career, he’s only seen 2 measles cases, and none in almost 35 years.

Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...